Cargando…

Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that exhibits aggressive tumor phenotypes, including rapid metastasis and tumor recurrence. Integrins belong to the family of transmembrane glycoproteins involved in regulating cell adhesion, proliferation, and differentiation throug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Jing, Peng, Shengkun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985445/ https://www.ncbi.nlm.nih.gov/pubmed/36879644 http://dx.doi.org/10.1515/biol-2022-0510

Ejemplares similares

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
por: Yin, Hsin-Ling, et al.
Publicado: (2016)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
por: Lin, Cai-Jin, et al.
Publicado: (2023)

Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer
por: Pleiko, Karlis, et al.
Publicado: (2023)

ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer
por: Chen, Mingcang, et al.
Publicado: (2022)

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways
por: Zhang, Yang, et al.
Publicado: (2020)

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2022)

RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers
por: De, Pradip, et al.
Publicado: (2016)

‘Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin
por: Abu-Tayeh, Hanan, et al.
Publicado: (2016)

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells
por: Wen, Yuqing, et al.
Publicado: (2019)

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
por: Hashmi, Atif Ali, et al.
Publicado: (2014)

Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
por: Derkaoui, Touria, et al.
Publicado: (2016)

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2017)

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Genomic features of rapid versus late relapse in triple negative breast cancer
por: Zhang, Yiqing, et al.
Publicado: (2021)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
por: Zheng, Chanjuan, et al.
Publicado: (2023)

Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis
por: Gupta, Nehal, et al.
Publicado: (2021)

Altered composition of the oral microbiome in integrin beta 6-deficient mouse
por: Uehara, Osamu, et al.
Publicado: (2022)

Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
por: Alanko, Johanna, et al.
Publicado: (2021)

Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2018)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
por: Ding, Jia-Han, et al.
Publicado: (2022)

Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
por: Peng, Fu, et al.
Publicado: (2022)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Nullomer peptide increases immune cell infiltration and reduces tumor metabolism in triple negative breast cancer mouse model
por: Ali, Nilufar, et al.
Publicado: (2023)

Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
por: O’Shaughnessy, Joyce, et al.
Publicado: (2022)

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Identify the triple-negative and non-triple-negative breast cancer by using texture features of medicale ultrasonic image: A STROBE-compliant study
por: Chen, Qingyu, et al.
Publicado: (2021)

α(v)β(3) integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo
por: Zhong, Ping, et al.
Publicado: (2017)

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer
por: Xu, Jiahui, et al.
Publicado: (2021)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

SH003 and Docetaxel Show Synergistic Anticancer Effects by Inhibiting EGFR Activation in Triple-Negative Breast Cancer
por: Choi, Yu-Jeong, et al.
Publicado: (2022)

Alpha6beta1 integrin expressed by sperm is determinant in mouse fertilization
por: Barraud-Lange, Virginie, et al.
Publicado: (2007)

Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype
por: Xu, Wen-Huan, et al.
Publicado: (2012)

TP 53 status and estrogen receptor-beta in triple negative breast cancer management in Africa: Time to rethink regime management of triple negative breast cancer and save more lives in Nigeria
por: Nzegwu, Martin Arinzechukwu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_spm1gqgkfhoqlrpdbcap8mtrtj